# FDA Inspection 1311564 - TEVA Pharmaceuticals USA, Inc. - July 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/teva-pharmaceuticals-usa-inc/d5e03df0-84ed-480b-bf0b-1df08945fb5a
Source feed: FDA_Inspections

> FDA Inspection 1311564 for TEVA Pharmaceuticals USA, Inc. on July 20, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1311564
- Company Name: TEVA Pharmaceuticals USA, Inc.
- Inspection Date: 2026-07-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1191141 - 2022-11-10](https://www.keypedia.com/records/fda_inspections/teva-pharmaceuticals-usa-inc/60b2f4fe-ba78-4567-ad4c-c73d6a6ae78d)
- [FDA Inspection 1040037 - 2018-01-11](https://www.keypedia.com/records/fda_inspections/teva-pharmaceuticals-usa-inc/bb3b39f4-5f1d-4221-9f77-4b74e308b804)
- [FDA Inspection 1000179 - 2017-02-01](https://www.keypedia.com/records/fda_inspections/teva-pharmaceuticals-usa-inc/62583c1b-220e-48ca-9d9e-1c0ccd28fe5c)
- [FDA Inspection 854234 - 2013-11-06](https://www.keypedia.com/records/fda_inspections/teva-pharmaceuticals-usa-inc/de9e5314-844d-4a31-a712-e760c576261a)
- [FDA Inspection 775065 - 2012-03-30](https://www.keypedia.com/records/fda_inspections/teva-pharmaceuticals-usa-inc/25359577-72ea-4700-a72f-11fb2422b5f8)

Company: https://www.keypedia.com/companies/teva-pharmaceuticals-usa-inc/80ca25b0-727b-44e6-aedf-39bf4f30ef14

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248